Related Experiment Video
Updated: Mar 7, 2026
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Matrix micro/nano-topography drives oncogenic signaling and drug response in a 3D osteosarcoma model
Mei-Ling Wang1, Xu Cai1, Feng Lv1
1Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Abstract:
Osteosarcoma (OS) research is constrained by a scarcity of clinical samples and traditional models that inadequately replicate the natural micro/nano-structure of bone. The role of these topological features in sustaining cellular function and influencing drug response remains insufficiently understood in OS. To address these challenges, a composite alginate-hydroxyapatite (AlgHA) cryogel was developed by incorporating bone-derived hydroxyapatite into an alginate-based cryogel matrix, which simultaneously enhanced mechanical stability and replicated the nano-topography of native bone extracellular matrix (ECM). The AlgHA-based OS model accurately reproduced key physiological characteristics, including cell proliferation, migration, and ECM protein remodeling. Notably, the model exhibited constitutive activation of multiple signaling pathways, such as PI3K-Akt, MAPK, and calcium signaling, which may be associated with malignant phenotypes. A comparative analysis of transcriptomic profiles and drug responses between 2D cultures and the AlgHA model has identified key pathways implicated in drug resistance, such as drug metabolism-cytochrome P450 and ATP-binding cassette transporters. Additionally, potential targets including receptor tyrosine kinases and PIK3CA, which are frequently overlooked in 2D cultures, were identified. These findings underscore the utility of the micro/nano-topological AlgHA cryogel as a physiologically relevant model for OS, facilitating mechanistic studies, therapeutic target identification, and drug sensitivity prediction. And this model presents a promising platform for advancing OS treatment strategies.
Insights
Researchers developed a novel alginate-hydroxyapatite cryogel model that mimics bone's micro/nano-structure. This advanced osteosarcoma (OS) model reveals new drug resistance pathways and potential therapeutic targets.
Area of Science:
- Biomaterials Science
- Cancer Research
- Tissue Engineering
Background:
- Osteosarcoma (OS) research faces limitations due to scarce clinical samples and inadequate traditional models.
- Existing models fail to replicate bone’s micro/nano-structure, hindering understanding of its role in cellular function and drug response in OS.
Purpose of the Study:
- To develop a physiologically relevant osteosarcoma model that replicates native bone micro/nano-topography.
- To investigate the impact of bone's topological features on OS cellular behavior and drug response.
- To identify novel therapeutic targets and predict drug sensitivity in osteosarcoma.
Main Methods:
- Fabrication of a composite alginate-hydroxyapatite (AlgHA) cryogel incorporating bone-derived hydroxyapatite.
- Characterization of the AlgHA cryogel for mechanical stability and nano-topography replication of bone extracellular matrix (ECM).
- Evaluation of the AlgHA-based OS model for physiological characteristics, signaling pathway activation, transcriptomic profiles, and drug responses compared to 2D cultures.
Main Results:
- The AlgHA cryogel successfully mimicked bone’s nano-topography and enhanced mechanical stability.
- The AlgHA-based OS model accurately reproduced OS cell proliferation, migration, and ECM remodeling, with activated PI3K-Akt, MAPK, and calcium signaling pathways.
- Comparative transcriptomic analysis identified drug resistance pathways (cytochrome P450, ABC transporters) and potential targets (receptor tyrosine kinases, PIK3CA) overlooked in 2D cultures.
Conclusions:
- The micro/nano-topological AlgHA cryogel serves as a physiologically relevant model for osteosarcoma research.
- This advanced model facilitates mechanistic studies, identification of therapeutic targets, and prediction of drug sensitivity in OS.
- The AlgHA cryogel platform holds promise for advancing osteosarcoma treatment strategies.
More Related Videos
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018